^
    Dropplex c-Met Exon14 Skipping Test is for non- small cell lung cancer (NSCLC, Non-Small Cell Lung Cancer) patients, in the presence of cMET Exon14 Skipping mutation by using RNA extracted from the patient's FFPE and whole blood. The test results can help with the selection of patients receiving ABN401, a targeted treatment.
    Cancer:
    Non Small Cell Lung Cancer
    Gene:
    MET (MET proto-oncogene, receptor tyrosine kinase)
    Drug:
    vabametkib (ABN401)
    Method:
    PCR
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    04/21/22
    LC
    MET
    CE